Cogent Biosciences
COGT
COGT
47 hedge funds and large institutions have $62.8M invested in Cogent Biosciences in 2018 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 22 increasing their positions, 9 reducing their positions, and 11 closing their positions.
Holders
47
Holders Change
-1
Holders Change %
-2.08%
% of All Funds
1.05%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
10
Increased
22
Reduced
9
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
BlackRock
New York
|
$6.73M |
| 2 |
SAM
2
Sectoral Asset Management
Montreal,
Quebec, Canada
|
$5.5M |
| 3 |
CI
3
Cowen Inc
New York
|
$3.6M |
| 4 |
4
Northern Trust
Chicago,
Illinois
|
$786K |
| 5 |
5
Two Sigma Investments
New York
|
$565K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Millennium Management
New York
| – | -$230K | -5,587 | Closed |
|
52
Squarepoint
New York
| – | -$200K | -4,850 | Closed |
|
53
Jane Street
New York
| – | -$150K | -3,630 | Closed |
|
54
UBS Group
Zurich,
Switzerland
| – | -$87K | -2,109 | Closed |
|
55
Barclays
London,
United Kingdom
| – | -$65K | -1,587 | Closed |
|
|
CCA
56
Catalyst Capital Advisors
Huntington,
New York
| – | -$6K | -149 | Closed |
|
57
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$2K | -42 | Closed |
|